Document:

Exhibit 10.3

 

CERTAIN
IDENTIFIED INFORMATION HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS BOTH NOT MATERIAL AND WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY
DISCLOSED, AND HAS BEEN MARKED WITH “[***]” TO INDICATE WHERE OMISSIONS HAVE BEEN MADE.

 

THIS
CONTRACT MANUFACTURING AGREEMENT (this “Agreement”) is entered into effect as of the 23rd day
of June, 2021 (the “Effective Date”) by and between MEDSCIENCE RESEARCH GROUP, INC., a Florida corporation
(“Manufacturer”), and USA EQUITIES CORP, (“Product Owner”). Manufacturer
and Product Owner are each referred to herein as a “Party” and collectively, the “Parties.”

 

RECITALS

 

WHEREAS,
Manufacturer is in the business of manufacturing products related to allergy diagnostics and allergen immunotherapy systems and related
components (all such products whether now or hereafter made available for sale by Manufacturer being hereinafter referred to as “Products”).

 

WHEREAS,
Product Owner wishes Manufacturer to produce Products for sale by Product Owner.

 

NOW,
THEREFORE, in consideration of the foregoing premises and the mutual representations and agreements set forth herein, and other good
and valuable consideration, the receipt and adequacy of which are hereby acknowledged, Manufacturer and Product Owner, intending to be
legally bound, hereby agree as follows:

 

1.
PURCHASE ORDERS; PRICING.

 

A.
Purchase Orders. Product Owner shall order Products in accordance with the terms and conditions of this Agreement. Each order for
the purchase of Products (a “Purchase Order”) must be submitted to Manufacturer by Product Owner by email to the email
address specified by Manufacturer. Each Purchase Order shall specify (i) the quantity of Products being ordered, (ii) the price to be
paid by Product Owner to Manufacturer for the Products ordered, (iii) payment terms granted by Manufacturer, and (iv) the requested receipt
date and delivery instructions for the applicable Products ordered. Receipt dates must be during the term of this Agreement, except Product
Owner may request, subject to Manufacturer’s acceptance in Manufacturer’s sole and absolute discretion, a Purchase Order
with a requested receipt date after the expiration or termination of this Agreement, in which case, if accepted by Manufacturer, the
terms and conditions of this Agreement shall apply to such shipment, but under no circumstances should such shipment be deemed to be
or construed as being a renewal or extension of this Agreement or the exclusivity rights granted to Product Owner herein. The Parties
agree that to the extent that any of the terms and conditions of this Agreement conflict or are inconsistent with the terms or conditions
of any Purchase Order submitted by Product Owner, the terms and conditions of this Agreement shall prevail and control to the extent
of any such conflict or inconsistency, unless the Purchase Order containing such conflicting or inconsistent terms and conditions is
countersigned by Manufacturer, in which case the terms and conditions set forth in such Purchase Order shall prevail and control to the
extent of any such conflict or inconstancy.

 

The
price to be paid for each Product is set forth on Exhibit A. Manufacturer shall not have the right to increase any price set forth on
Schedule A without giving Product Owner 90 days prior notice of such increase.

 

    	 

     

    

 

B.
Acceptance of Purchase Order. A Purchase Order submitted by Product Owner shall be deemed to have been accepted by, and shall be
binding upon, Manufacturer when it is countersigned by Manufacturer or if it is not rejected by Manufacturer, in whole or in part, by
written notice to Product Owner sent within five (5) business days of its receipt by Manufacturer. Notwithstanding anything contained
herein to the contrary, Manufacturer may only reject, cancel, or delay any Purchase Order placed by Product Owner which it has been deemed
to have accepted, pursuant to Section 3.B. below. In the event Manufacturer is unable to fill all of a Purchase Order for any reason,
it shall promptly notify Product Owner and Product Owner shall have the right, in its discretion, to cancel the subject Purchase Order.
Product Owner may change or cancel any of its Purchase Orders without penalty so long as Product Owner provides written notice to Manufacturer
and the Products have not yet been shipped; provided that Product Owner shall pay to Manufacturer a fee of twenty five percent
(25%) of the aggregate purchase price of the Products of which manufacturing has commenced that are subject to any Purchase Order which
has been materially changed or canceled by Product Owner.

 

C.
Invoices and Payment Terms. Manufacturer shall send Product Owner invoices via mail or email for each shipment. Product Owner shall
notify Manufacturer in writing if Product Owner disputes any charges set forth on an invoice within fifteen (15) calendar days after
receipt of such invoice, specifying in reasonable detail the items disputed and basis for the dispute. Thereafter, the Parties will work
in good faith to resolve such dispute as quickly as is reasonably possible. If any such dispute is not resolved within sixty (60) calendar
days after Product Owner’s receipt of the applicable invoice, then Manufacturer may refuse to accept any new Purchase orders under
this Agreement until such time as the dispute is resolved and all amounts agreed upon by the Parties to be due are paid in full. All
undisputed amounts on each invoice are due and payable within thirty (30) calendar days from the date of Product Owner’s receipt
of the invoice. Payments due hereunder must be made, at Product Owner’s option, by ACH, wire transfer, certified check or such
other method as may be agreed to by the Parties. Manufacturer reserves the right to change or modify payment terms upon sixty (60) calendar
days’ written notice to Product Owner at any time following a default by Product Owner of its payment obligations under this Agreement
with such changes or modifications to be effective for Purchase Orders submitted after such sixty (60) calendar day period. Invoices
will be issued upon shipment of the product from Manufacturer’s warehouse or production facility to Product Owner or to Product
Owner’s customer via direct shipment.

 

D.
Past Due Amounts. If any undisputed amount due Manufacturer by Product Owner, for any reason, becomes past due, Manufacturer shall
provide written notice to Product Owner and, if such amounts remain outstanding for fifteen (15) calendar days following receipt of such
notice, Manufacturer may at its option and without further notice withhold further shipments or deliveries of Products under this Agreement
until such past due invoices are paid in full.

 

E.
Taxes. Product Owner shall be responsible for any national, state or local sales, use, value added, or other tax, tariff, duty or
assessment levied or imposed by the United States or any foreign governmental authority arising out of or related to any of the transactions
contemplated by this Agreement, including sales of Product to Product Owner, other than taxes based upon Manufacturer’s income.
Product Owner must pay directly, or reimburse Manufacturer for the amount of such sales, use, value added or other tax, tariff, duty
or assessment which Manufacturer is at any time obligated to pay or collect with respect to or arising out of the sale of Products under
this Agreement.

 

    	 

     

    

 

2.
SHIPMENTS; PRODUCTS.

 

A.
Shipment Terms; Title and Risk of Loss. All Products purchased by Product Owner under this Agreement will be packaged for shipment
in Manufacturer’s standard containers, marked for shipment in the case of any purchase by Product Owner of Products from Manufacturer
for sale to Physician Customer at the address specified by Product Owner in the Purchase Order (the applicable destination being hereinafter
referred to as the “Destination”). All costs of shipment shall be paid by Manufacturer for any purchase by Product
Owner of Products from Manufacturer for sale to Physician Customers (and all such Products shall be directly shipped by Manufacturer
to each such Physician Customer at the address specified by Product Owner in the applicable Purchase Order unless Product Owner requests
that the Product be shipped to it). Title and risk of loss will pass F.O.B. Destination. For Products shipped to Product Owner, Product
Owner shall be solely responsible for all costs of shipment for the subsequent sale by Product Owner to Physician Customers. Manufacturer
shall ship Products on or before the requested receipt date designated in a Purchase Order (provided that such receipt date is not less
than twenty (20) business days after the Purchase Order is received by Manufacturer) and shall promptly notify Product Owner when Manufacturer
knows or has reason to believe that a shipment will not be delivered by the requested receipt date. Any expense for any special packaging
or any special delivery requested by Product Owner shall be borne by Product Owner.

 

B.
Manufacturer’s Right to Delay or Cancel. Notwithstanding Manufacturer’s obligations in this Agreement, Manufacturer may
refuse, cancel or delay any shipment of Products when Product Owner is delinquent in any payment for more than (30) calendar days, or
when Product Owner is in material breach of its obligations under this Agreement which has not been cured pursuant to Section 11.A.

 

C.
Acceptance of Shipments. Product Owner shall have ten (10) business days from the date of arrival of the shipment of the Products
at the applicable Destination or other shipping location agreed upon by the Parties to inspect the Products and notify Manufacturer in
writing of any discrepancies with respect to such Products, including but not limited to any discrepancies in the quantity or quality
of the Products. Products with respect to which Product Owner does not notify Manufacturer of any discrepancies in writing shall be deemed
accepted by Product Owner.

 

3.
INTELLECTUAL PROPERTY RIGHTS.

 

Manufacturer’s Marks. Unless otherwise directed by Product Owner, Products shall bear and shall be shipped in packaging bearing
Manufacturer’s logos, trademarks, and trade names, and shall be accompanied by branding and marketing materials created by or on
behalf of Manufacturer. Manufacturer shall give Product Owner ninety (90) days’ notice of Manufacturer’s intent to change
the containers or packaging for Products or the logos, trademarks, and trade names, and branding and marketing materials used in connection
with the Products. Manufacturer hereby grants to Product Owner a revocable, non-transferable, non-exclusive, limited license to use Manufacturer’s
logos, trademarks, and trade names, together with all branding and marketing materials created by or on behalf of Manufacturer in connection
with the Products, (collectively the “Manufacturer IP”), solely in connection with the marketing, advertisement and
sale of the Products. Such license shall immediately terminate upon the expiration or termination of this Agreement. Product Owner shall
strictly comply with all standards of use for the Manufacturer IP and must at all times display appropriate trademark and copyright notices
as instructed by Manufacturer. Product Owner acknowledges and agrees that the Manufacturer IP and other intellectual property provided
to Product Owner by Manufacturer, if any, are the sole and exclusive property of Manufacturer. Product Owner shall not acquire any right,
title or interest under this Agreement in any patent, copyright, Manufacturer IP or other intellectual property right of any kind of
Manufacturer. No implied license, patent, copyright or other intellectual property right of Manufacturer is granted under this Agreement
or otherwise. During the term of this Agreement and thereafter, Product Owner shall not do anything that will in any manner infringe,
impeach, dilute or lessen the value of the Manufacturer IP, patents, copyrights or other intellectual property of Manufacturer or the
goodwill associated therewith or that will tend to prejudice the reputation of the Manufacturer or the sale of any Products.

 

    	 

     

    

 

4.
CONFIDENTIAL INFORMATION.

 

A.
Confidential Information. The Parties acknowledge and agree that during the term of this Agreement, each may receive confidential
information from the other Party. “Confidential Information” shall mean (i) information relating to a Party’s
and its affiliates’ products or business including, but not limited to, the business plans, financial records, customers, suppliers,
products, product samples, strategies, inventions, procedures, sales aids or literature, technical data, advice or knowledge, contractual
agreements, pricing, price lists, product white papers, plans, designs, specifications, and know-how or other intellectual property,
that may be at any time furnished, communicated or delivered by either party to the other party whether in oral, tangible, electronic
or other form and (ii) all other non-public information provided by one Party to the other including, but not limited, to financial,
technical and business information, and all non-promotional materials furnished by one Party to another.

 

B.
Exceptions. The “Receiving Party” shall not have any obligations to preserve the confidential nature of any Confidential
Information that (a) Receiving Party can demonstrate by competent evidence was rightfully in the Receiving Party’s possession before
receipt from the “Disclosing Party”; (b) is or becomes a matter of public knowledge through no fault of the Receiving
Party; (c) is rightfully received by Receiving Party from a third party without, to the best of Receiving Party’s knowledge, a
duty of confidentiality; (d) is independently developed by Receiving Party without use of the Confidential Information; or (e) is disclosed
by Receiving Party with Disclosing Party’s prior written approval.

 

C.
Use of Confidential Information; Standard of Care. The Receiving Party shall maintain the Confidential Information in confidence
and disclose the Confidential Information only to its employees, subcontractors and consultants who have a need to know such Confidential
Information in order to fulfill the business affairs and transactions between the Parties contemplated by this Agreement and who are
under confidentiality obligations no less restrictive as, or who have been advised of the confidentiality obligations set forth in, this
Agreement. The Receiving Party shall remain responsible for breaches of this Agreement arising from the acts of its employees, subcontractors
and consultants to whom it provides the Disclosing Party’s Confidential information. The Receiving Party shall protect Confidential
Information by using the same degree of care as Receiving Party uses to protect its own information of a like nature, but no less than
a reasonable degree of care, to prevent the unauthorized use, disclosure, dissemination, or publication of the Confidential Information.
The Receiving Party agrees not to use the Disclosing Party’s Confidential Information for its own purpose other than in connection
with the transactions contemplated by this Agreement or for the benefit of any third party, without the prior written approval of the
Disclosing Party. The Receiving Party shall promptly return or certify destruction of all copies of Confidential Information upon request
by the Disclosing Party or upon the expiration or earlier termination of this Agreement.

 

D.
Equitable Relief. The Receiving Party hereby agrees and acknowledges that any breach or threatened breach of this Agreement regarding
the treatment of the Confidential Information may result in irreparable harm to the Disclosing Party for which there may be no adequate
remedy at law. In addition to other remedies provided by law or at equity, in such event the Disclosing Party shall be entitled to seek
an injunction, without bond, preventing any further breach of this Agreement by the Receiving Party.

 

    	 

     

    

 

5.
INSURANCE. Manufacturer shall maintain, during the term of this Agreement, Commercial General Liability Insurance with minimum limits,
including under any General Liability Umbrella Policies, of not less than $2,000,000 combined single limit for bodily injury and property
damage on Products purchased by Product Owner for resale. Manufacturer shall use commercially reasonable efforts to provide Product Owner
with thirty (30) calendar days’ prior written notice of any change or cancellation in any applicable insurance policies.

 

Product
Owner shall maintain, during the term of this Agreement, Commercial General Liability Insurance with minimum limits, including under
any General Liability Umbrella Policies, of not less than $2,000,000 combined single limit for bodily injury and property damage. Product
Owner shall use commercially reasonable efforts to provide Manufacturer with thirty (30) calendar days’ prior written notice of
any change or cancellation in any applicable insurance policies.

 

6.
WARRANTY; RECALL.

 

A.
Warranty. Manufacturer warrants to Product Owner, for a period of one year from the date of delivery by Manufacturer to the intended
recipient thereof, that any Products delivered by Manufacturer pursuant to this Agreement shall conform in all material respects to Manufacturer’s
written specifications for such Products, and shall be free of defects in materials and workmanship. Manufacturer further warrants to
Product Owner that it has title to the Products to be conveyed hereunder and has the right to sell the same and that at the time of delivery,
such Products shall be free of any security interest or other lien or any other encumbrances whatsoever (the warranties provided in the
preceding two sentences being hereinafter referred to as the “Limited Warranty”). Except for the Limited Warranty,
Manufacturer makes no warranties or representations to Product Owner or any other person with respect to the Products or any services
provided to Product Owner or any other person. Manufacturer may not change any of the terms of the Limited Warranty at any time, without
written consent from Product Owner unless Manufacturer notifies Product Owner in writing at least one hundred and twenty (120) calendar
days prior to any such change. Any such change shall not apply to any Products sold to or ordered by Product Owner prior to the change.
Product Owner will not alter the Limited Warranty, warranty disclaimers and limitation of liability without the prior written authorization
of Manufacturer, nor extend or make any additional warranty or representation regarding the Products unless expressly authorized by Manufacturer.

 

THE
LIMITED WARRANTY REFERRED TO IN THIS SECTION IS THE ONLY WARRANTY, EXPRESS OR IMPLIED, THAT MANUFACTURER MAKES WITH RESPECT TO THE PRODUCTS.
MANUFACTURER SPECIFICALLY DISCLAIMS ALL OTHER IMPLIED WARRANTIES INCLUDING, WITHOUT LIMITATION, THE IMPLIED WARRANTIES OF MERCHANTABILITY,
FITNESS FOR A PARTICULAR PURPOSE AND NON-INFRINGEMENT.

 

B.
Warranty Claims. The Limited Warranty is effective only if Product Owner gives prompt written notice to Manufacturer of any alleged
breach of the Limited Warranty, which notice shall specifically describe the problem and shall state the date of sale and name and location
of the recipient of the Product originally shipped by Manufacturer. Notwithstanding anything to the contrary contained herein, Manufacturer
shall have no obligation under the Limited Warranty unless it receives such notice within thirty (30) days following the expiration of
the warranty period. In the event of any breach of the Limited Warranty Manufacturer’s sole obligation is to replace each non-conforming
Product within a reasonable period of time and to pay for the costs of shipment to the original recipient of the Product or as otherwise
specified by Product Owner.

 

    	 

     

    

 

C.
Recall. In the event that: (i) any applicable federal, state or foreign regulatory authority should issue a request, directive or
order that a Product be recalled; (ii) a court of competent jurisdiction orders such a recall or; (iii) Manufacturer determines that
the Product represents a risk of injury or customer deception or is otherwise defective and that the recall of a Product is appropriate
(“Recall”), Manufacturer shall have sole right and responsibility for implementing the Recall. Product Owner will
provide cooperation and assistance to Manufacturer in connection therewith, as may be reasonably requested by Manufacturer. Manufacturer
shall be solely responsible for all expenses affecting such Recall (including any reasonable out-of-pocket expenses incurred by Product
Owner in connection with such cooperation, as directed in writing by Manufacturer).

 

7.
INDEMNIFICATION.

 

A.
Indemnity Obligations for Intellectual Property Infringement. Manufacturer agrees to defend, indemnify and hold harmless Product
Owner from and against any and all claims, losses, damages, suits, expenses (including reasonable attorneys’ fees) and costs (collectively
“Claims”) brought or alleged by a third party that the Manufacturer IP or any Products sold to Product Owner infringe
any U.S. patent, trademark or copyright. Product Owner shall reasonably cooperate with Manufacturer, its insurance company and its legal
counsel in its defense of such Claims. If the use or sale of any Products furnished under this Agreement is enjoined as a result of a
Claim, Manufacturer shall either obtain on behalf of the Product Owner the right to continue to use or sell such Products, substitute
an equivalent product reasonably acceptable to Product Owner in its place, or reimburse Product Owner the purchase price of the Products,
costs incurred by Product Owner as a result of such cancellation, and any and all losses or costs incurred as a result of Product Owner’s
breach of any purchaser order or other agreement with its customers. Notwithstanding the foregoing, this indemnity shall not apply or
cover any Claims based upon any infringement or alleged infringement of any patent, trademark or copyright resulting from the alteration
or unauthorized (by Manufacturer) use of any Manufacturer IP or Products by Product Owner or a Product Owner representative or the combination
of any Products with any other products or the combination of any Manufacturer IP with any other mark, if such infringement claim would
have been avoided but for such alteration, combination or unauthorized use by Product Owner or any Product Owner representative. Product
Owner shall also have the right to participate in the defense of any such action and have the right to hire its own legal counsel at
Product Owner’s expense. This indemnity shall not cover any Claims in which Product Owner fails to provide Manufacturer with prompt
written notice of the Claim which lack of notice materially prejudices the defense of the Claim.

 

B.
Manufacturer’s Additional Indemnity Obligations. Notwithstanding anything herein to the contrary, in addition to all other
rights and remedies available at law or in equity, Manufacturer hereby agrees to defend, indemnify and hold harmless Product Owner from
and against any and all third party Claims (i) arising out of any defects in any Products existing at the time such Products are sold
by Manufacturer to Product Owner, or (ii) arising out of the negligent acts or omissions or willful misconduct of Manufacturer, its employees,
agents or representatives with respect to the Products or its performance of this Agreement. Product Owner shall reasonably cooperate
with Manufacturer, its insurance company and its legal counsel in its defense of such Claims. Product Owner shall also have the right
to participate in the defense of any such action and have the right to hire its own legal counsel at Product Owner’s expense. This
indemnity shall not cover any Claims in which Product Owner fails to provide Manufacturer with prompt written notice of the Claim which
lack of notice materially prejudices the defense of the Claim.

 

    	 

     

    

 

C.
Product Owner’s Indemnity Obligations to Manufacturer. Product Owner hereby agrees to defend, indemnify and hold harmless Manufacturer,
its affiliates and their respective officers directors, employees and agents from and against any and all Claims (i) arising out of the
negligent acts or omissions or willful misconduct of Product Owner, its employees, agents or representatives with respect to its performance
of this Agreement, sale of Products, or otherwise, (ii) arising out of the alteration or modification of the Products or Manufacturer
IP by Product Owner or its employees, agents or representatives, or (iii) alleging that the Product Owner’s Marks infringe or otherwise
violate the intellectual property rights of a third party. This indemnity shall not cover any Claims in which Manufacturer fails to provide
Product Owner with prompt written notice which lack of notice prejudices the defense of the Claim. Manufacturer shall also have the right
to participate in the defense of any such action and have the right to hire its own legal counsel at Manufacturer’s expense.

 

D.
Settlement of Claims. In no event shall a party seeking or entitled to indemnification from a Party hereunder settle, compromise,
agree to a judgment or take any similar action with respect to any Claim without the written consent of the Party from whom indemnification
is sought.

 

8.
LIMITATION OF LIABILITY.

 

EXCEPT
FOR THE PARTIES’ INDEMNIFICATION OBLIGATIONS UNDER SECTION 8 OF THIS AGREEMENT AND CONFIDENTIALITY OBLIGATIONS UNDER SECTION 5
OF THIS AGREEMENT, IN NO EVENT SHALL EITHER PARTY BY LIABLE UNDER THIS AGREEMENT TO THE OTHER PARTY FOR ANY INCIDENTAL, CONSEQUENTIAL,
INDIRECT, STATUTORY, SPECIAL, OR PUNITIVE DAMAGES, INCLUDING, BUT NOT LIMITED TO, LOST PROFITS, LOSS OF USE, LOSS OF TIME, INCONVENIENCE,
LOSS BUSINESS OPPORTUNITIES, DAMAGE TO GOOD WILL OR REPUTATION, OR LOSS OF DATA, REGARDLESS OF WHETHER SUCH LIABILITY IS BASED ON BREACH
OF CONTRACT, TORT, STRICT LIABILITY OR OTHERWISE, AND EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES OR SUCH DAMAGES COULD HAVE BEEN
REASONABLY FORESEEN.

 

9.
TERM. This Agreement shall commence on the Effective Date and shall end on the tenth anniversary of the Effective Date (the “Initial
Term”) unless earlier terminated pursuant to Section 11 hereof. The Initial Term shall automatically renew for successive renewal
terms of five (5) years each (each, a “Renewal Term”), unless either Party provides the other Party with written notice
of its intention not to renew the Initial Term or any Renewal Term, as applicable, at least sixty (60) days prior to the expiration of
the then current Initial Term or Renewal Term.

 

10.
TERMINATION.

 

A.
Termination for Breach. Either Party may terminate this Agreement at any time in the event of a material breach by the other Party
that remains uncured after thirty (30) calendar days following written notice thereof. Such termination shall be effective immediately
and automatically upon the expiration of the applicable notice period, without further notice or action by either Party. Termination
shall be in addition to any other remedies that may be available to the non-breaching Party.

 

    	 

     

    

 

B.
Termination for Financial Insecurity. Either Party may terminate this Agreement and any outstanding Purchase Orders (to the extent
Products have not already been delivered to the carrier for shipment) immediately at its option upon written notice if the other Party:
(i) becomes or is declared insolvent or bankrupt; (ii) is the subject of a voluntary or involuntary bankruptcy or other proceeding related
to its liquidation or solvency, which proceeding is not dismissed within sixty (60) calendar days after its filing; (iii) ceases to do
business in the normal course; or (iv) makes an assignment for the benefit of creditors. This Agreement shall terminate immediately and
automatically upon any determination by a court of competent jurisdiction that either Party is excused or prohibited from performing
in full all obligations hereunder, including, without limitation, rejection of this Agreement pursuant to 11 U.S.C. §365.

 

C.
Obligations upon Termination. Upon termination of this Agreement, Product Owner shall cease to be an authorized reseller of the Products
and shall have no right to use Manufacturer’s IP other than in connection with the liquidation of Product on hand or received after
the date of termination and (i) all unaccepted Purchase Orders may be cancelled by Product Owner or Manufacturer without liability, and
(ii) Product Owner may, at its option, resell and deliver to Manufacturer, free and clear of all liens and encumbrances, any or all Products
that (A) are subject to Purchase Orders accepted by Manufacturer whether or not the applicable Products have been shipped as of the date
of termination and (B) were manufactured, shipped or received as of the date of termination, in each case that are in new condition and
in the original factory packaging at the original purchase price of any such Products that Product Owner elects to resell to Manufacturer
less a restocking charge of 50% of such amount payable by Manufacturer upon receipt of such Products. Restocking is waived in the event
the Manufacturer terminates Product Owner, other than if termination is a Termination for Breach as outlined in 10.A. Within ninety (90)
calendar days of termination of this Agreement, Product Owner shall remove and not thereafter use any sign, display, or other advertising
or marketing means containing Manufacturer Marks, except as provided in this section. Product Owner may continue to use in-store materials
containing the Manufacturer’s IP as reasonably required for the resale of the Products which may be remaining in Product Owner’s
possession after termination, which materials Product Owner may continue to utilize until all remaining Products have been sold or one
hundred eighty (180) calendar days after termination, whichever comes first, after which Product Owner shall cease the use of any such
Manufacturer IP.

 

11.
COMPLIANCE WITH LAWS. Product Owner acknowledges and understands that the Products may be subject to restrictions upon export from
the United States and upon resale after export. Product Owner therefore represents and warrants that it shall comply fully with all relevant
regulations of the U.S. Department of Commerce, with the U.S. Export Administration Act, and with any other import and/or export control
laws or regulations of the United States or any other jurisdiction.

 

12.
GENERAL TERMS.

 

A.
Independent Contractors. Nothing in this Agreement, and no course of dealing between the Parties, shall be construed to create or
imply an employment or agency relationship or a partnership or joint venture relationship between the Parties or between one Party and
the other Party’s employees or agents. Neither Manufacturer nor Product Owner has the authority to bind the other, to incur any
liability or otherwise act on behalf of the other. Each Party shall be solely responsible for payment of its employees’ salaries
(including withholding of income taxes and social security), workers compensation, and all other employment benefits.

 

    	 

     

    

 

B.
Assignment. Neither this Agreement, nor any right or interest herein, may be assigned, in whole or in part, without the express written
consent of the other Party. Any assignment without such consent shall be null and void. Notwithstanding the foregoing, the Product Owner
may subcontract its rights or obligations under this Agreement with the prior written consent of Manufacturer. Either party may assign
this Agreement if the assignment is carried out as part of a merger, restructuring, or reorganization, or sale or transfer of all or
substantially all of a Party’s assets. This Agreement shall be binding upon and inure to the benefit of the Parties hereto, their
successors and legal representatives. Except as set forth in Section 8, there are no third-party beneficiaries to this Agreement.

 

C.
Notices. Unless otherwise agreed to by the Parties, all notices shall be deemed effective when received and made in writing by either
(i) certified mail, return receipt requested, (ii) nationally recognized overnight courier, or (iii) fax with confirmation, addressed
to the party to be notified at the following address or to such other address as such Party shall specify by like notice hereunder:

 

If
to Manufacturer:

MEDSCIENCE
RESEARCH GROUP, INC.

16469
BRIDLEWOOD CIR

DELRAY
BEACH, FL 33445 

	 	Attn:	MEDSCIENCE
    - CORPORATE
	 	Email:	[***]

	 	Fax:	561-258-0533

 

If
to Product Owner:

 

USA
EQUITIES CORP

901
Northpoint Parkway, Suite 302.

WEST
PALM BEACH, FL 33407 

	 	Attn:	USA
    EQUITIES CORP - CORPORATE 
	 	Email:	[***]

	 	Fax:	561-258-0533

 

(with
a copy to, which does not serve as notice):

 

Mandelbaum
Salsburg Attorneys at Law

1270
Avenue of the Americas

Suite
1808

NEW
YORK, NY 10020

Attn:
VINCENT McGILL

Email:
[***]

Fax:
917-383-1228

 

Either
Party, by written notice to the other pursuant to this section, may change its address or designees for receiving such notices.

 

D.
Force Majeure. Neither Party shall liable hereunder for any failure or delay in the performance of its obligations under this Agreement
if such failure or delay is on account of causes beyond its control, including labor disputes, civil commotion, war, fires, floods, inclement
weather, governmental regulations or controls, casualty, government authority, strikes, or acts of God, in which event the non-performing
party shall be excused from its obligations for the period of the delay and for a reasonable time thereafter. Each Party shall use reasonable
efforts to notify the other Party of the occurrence of such an event within three (3) business days of its occurrence.

 

    	 

     

    

 

E.
Governing Law; Venue; Jury Waiver. This Agreement shall be governed by the laws of the State of Florida, without giving effect to
the principles of conflicts of law of such state and shall be binding upon the Parties hereto in the United States and worldwide. Any
claims or legal actions by one Party against the other arising under this Agreement or concerning any rights under this Agreement shall
be commenced and maintained in any state or federal court located in Palm Beach County, Florida. Both Parties hereby submit to the jurisdiction
and venue of any such court. THE PARTIES FURTHER AGREE, TO THE EXTENT PERMITTED BY APPLICABLE LAW, TO WAIVE ANY RIGHT TO TRIAL BY JURY
WITH RESPECT TO ANY CLAIM, COUNTERCLAIM OR ACTION ARISING FROM THE TERMS OF THIS AGREEMENT.

 

F.
Attorney’s Fees. If either Party incurs any legal fees associated with the enforcement of this Agreement or any rights under
this Agreement, the prevailing Party shall be entitled to recover its reasonable attorney’s fees and any court, arbitration, mediation,
or other litigation expenses from the other Party.

 

G.
Survival. The provisions of this Agreement which by their sense and context should survive any termination of expiration of this
Agreement, including without limitation sections 4 (confidentiality), 6 (warranty), 7 (indemnification), 8 (limitation of liability),
11 (compliance with laws) and 12 (general terms) shall so survive.

 

H.
Authorized Signatories. It is agreed and warranted by the Parties that the individuals singing this Agreement on behalf of the respective
Parties are authorized to execute such an agreement. No further proof of authorization shall be required.

 

I.
Severability. If any provision or portion of this Agreement shall be held by a court of competent jurisdiction to be illegal, invalid,
or unenforceable, the remaining provisions or portions shall remain in full force and effect.

 

J.
No Strict Construction. This Agreement shall not be construed more strongly against either party regardless of which party is more
responsible for its preparation.

 

K.
Counterparts. This Agreement may be executed by facsimile and in one or more counterparts, each of which will be deemed to be an
original, but all of which together will constitute one and the same instrument, without necessity of production of the others.

 

L.
Entire Agreement; Modification; Waiver. This Agreement is the entire agreement between the Parties with respect to the subject matter
and supersedes any prior agreement or communications between the Parties hereto, whether written or oral. This Agreement may be modified
only by a written amendment signed by authorized representatives of both Parties. No waiver of any term or right in this Agreement shall
be effective unless in writing, signed by an authorized representative of the waiving Party. The failure of either Party to enforce any
provision of this Agreement shall not be construed as a waiver or modification of such provision, or impairment of its right to enforce
such provision thereafter.

 

[SIGNATURES
ON FOLLOWING PAGE]

 

    	 

     

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Distribution Agreement to be duly executed by their duly authorized representatives
as of the Effective Date.

 

	 	MANUFACTURER
	 	 	 
	 	MEDSCIENCE
    RESEARCH GROUP, INC.
	 	 	 
	 	By:	/s/
    Marvin Smollar
	 	Name:	Marvin
    Smollar
	 	Title:	Senior
    Manager
	 	 	 
	 	PRODUCT
    OWNER
	 	 	 
	 	USA
    EQUITIES CORP.
	 	 	 
	 	By:	/s/
    Troy Grogan
	 	Name:	Troy
    Grogan
	 	Title:	Chief
    Executive Officer

 

    	 

     

    

 

Exhibit
A

 

The
Product Owner’s Product Pricing from Manufacturer is as follows:

 

Item
4200, the complete AllergiEnd 42 test Kit (Environmental)................... [***]

 

Item
3600, the complete AllergiEnd 42 test Kit (Food)................................. [***]

 

Item
1038, AllergiEnd Low Dose Sublingual Immunotherapy (SLIT) Unit.......... [***]

 

Item
1039, AllergiEnd Maintenance Dose Sublingual Immunotherapy (SLIT) Unit[***]

 

Item
3007 to 3008 Allergen Subcutaneous Injectable Mixtures (SCIT) per 46 dose set [***]

 

Item
3009 Allergen Subcutaneous Injectable Maintenance 12 Dose vial [***]Document

Exhibit 10.1

AMENDMENT NO. 2 TO FOURTH AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT 
This AMENDMENT NO. 2 TO FOURTH AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT is dated as of June 22, 2021 (this “Amendment”), among AMERESCO, INC. (the “Borrower”), THE GUARANTORS PARTY HERETO (the “Guarantors” and collectively with the Borrower, the “Loan Parties”), THE LENDERS PARTY HERETO (the “Lenders”), and BANK OF AMERICA, N.A., as administrative agent (the “Agent”).
WHEREAS, the Loan Parties, the Lenders, and the Agent are parties to that certain Fourth Amended and Restated Credit and Security Agreement dated as of June 28, 2019, as amended by Amendment No. 1 to Fourth Amended and Restated Credit and Security Agreement dated as of March 31, 2020, among the Borrower, the Guarantors, the Lenders, and the Agent (as amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”);
WHEREAS, the Loan Parties, the Agent and the Lenders wish to increase the Revolving Credit Commitment of the Lenders and make certain changes to the Credit Agreement, and accordingly revise certain provisions of the Credit Agreement, as described herein;
NOW, THEREFORE, in consideration of the foregoing and the agreements contained herein, the parties agree that the Credit Agreement is hereby amended as follows:
1.Capitalized Terms. Except as otherwise expressly defined herein, all capitalized terms used herein which are defined in the Credit Agreement have the same meanings herein as therein, except to the extent that such meanings are amended hereby.
2.Amendment to Credit Agreement.
(a)Section 1.01 of the Credit Agreement is hereby amended to delete the definitions of  “Alternative Currency Equivalent,” “Ameresco Huntington Beach,” “Eurocurrency Rate,” “Funding Subsidiaries,” “Interest Payment Date,” “Material Indebtedness,” “Non-Core Energy Project,” “Non-Core Energy Project Guaranty,” “Non-Core Energy Subsidiary,” “Restricted Junior Payment” and “Special Purpose Subsidiaries” in their entirety and replace them with the following new definitions of such terms:
“Alternative Currency Equivalent” means, at any time, with respect to any denominated in Dollars, the equivalent amount thereof in the applicable Alternative Currency as determined by the Agent or the L/C Issuer, as the case may be, by reference to Bloomberg (or such other publicly available service for displaying exchange rates), to be the exchange rate for the purchase of such Alternative Currency with Dollars at approximately 11:00 a.m. on the date two (2) Business Days prior to the date as of which the foreign exchange computation is made; provided, however, that if no such rate is available, the “Alternative Currency Equivalent” shall be determined by the Agent or the L/C Issuer, as the case may be, using any reasonable method of determination its deems appropriate in its sole discretion (and such determination shall be conclusive absent manifest error).
“Eurocurrency Rate” means: 
(a)    (x) with respect to any Credit Extension denominated in Sterling (or any other Alternative Currency that bears interest at a daily rate), the applicable Alternative Currency Daily 
1

Rate and (y) for any Interest Period, with respect to any Credit Extension denominated in Dollars or any Alternative Currency other than Sterling;
i.    denominated in Dollars, the rate per annum equal to the London Interbank Offered Rate as administered by ICE Benchmark Administration (or any other Person responsible for the administration of such rate for U.S. Dollars for a period equal in length to such Interest Period) (“LIBOR”), as published on the applicable Reuters screen page (or such other commercially available source providing such quotations as may be designated by the Agent from time to time) (in such case, the “LIBOR Rate”) on the Rate Determination Date, for deposits in the relevant currency, with a term equivalent to such Interest Period; 
ii.    denominated in Euros, the rate per annum equal to the Euro Interbank Offered Rate (“EURIBOR”), as published on the applicable Reuters screen page (or such other commercially available source providing such quotations as may be designated by the Agent from time to time) on the day that is two TARGET Days preceding the first day of such Interest Period with a term equivalent to such Interest Period; and
iii.         denominated in Canadian Dollars, the rate per annum equal to the Canadian Dollar Offered Rate (“CDOR”), or a comparable or successor rate which rate is approved by the Agent, as published on the applicable Reuters screen page (or such other commercially available source providing such quotations as may be designated by the Agent from time to time) (in such case, the “CDOR Rate”) on the Rate Determination Date with a term equivalent to such Interest Period; and
(b)    for any interest rate calculation with respect to a Base Rate Loan on any date, the rate per annum equal to the LIBOR Rate, at or about 11:00 a.m. (London time) determined two (2) Business Days prior to such date for Dollar deposits being delivered in the London interbank market for deposits in Dollars with a term of one (1) month commencing that day; 
provided that (i) to the extent a comparable or successor rate is approved pursuant to Section 3.03, the approved rate shall be applied in a manner consistent with market practice; provided, further that, to the extent such market practice is not administratively feasible for the Agent, such approved rate shall be applied in a manner as otherwise reasonably determined by the Agent, and (ii) if the Eurocurrency Rate shall be less than zero percent (0%), such rate shall be deemed to be zero percent (0%) for purposes of this Agreement.
“Interest Payment Date” means, (a) as to any Loan other than a Base Rate Loan or Alternative Currency Daily Rate Loan, the last day of each Interest Period applicable to such Loan and the Maturity Date of the Facility under which such Loan was made; provided, however, that if any Interest Period for a Eurocurrency  Rate Loan exceeds three (3) months, the respective dates that fall every three (3) months after the beginning of such Interest Period shall also be Interest Payment Dates; (b) as to any Base Rate Loan, Swing Line Loan or Alternative Currency Daily Rate Loan, the last Business Day of each March, June, September and December and the Maturity Date of the Facility under which such Loan was made (with Swing Line Loans being deemed made under the Revolving Facility for purposes of this definition); and (c) upon the earlier acceleration of the Loans pursuant to Section 10.02. 
2

“Material Indebtedness” means Indebtedness (other than the Loans or Letters of Credit), including, without limitation, obligations in respect of one or more Hedging Agreements, in an aggregate principal amount exceeding $10,000,000.  For purposes of determining Material Indebtedness, the “principal amount” of the obligations of any Person in respect of a Hedging Agreement at any time shall be the maximum aggregate amount (giving effect to any netting agreements) that such Person would be required to pay if such Hedging Agreement were terminated at such time.
“Non-Core Energy Project” means (i) any Renewable Energy Project and (ii) any other energy or other utility infrastructure project other than an Energy Conservation Project.
“Non-Core Energy Project Guaranty” means in connection with any Non-Core Energy Project, (a) any Guarantee (other than a Construction Completion and Cost Overrun Guaranty) by the Borrower or a Foreign Subsidiary of the obligations of the Non-Core Energy Subsidiary in connection with such Non-Core Energy Project and (b) any indemnification by or from the Borrower or a Foreign Subsidiary of the Non-Core Energy Subsidiary’s customer or the owner of property used for such Non-Core Energy Project or of a third party purchaser of gas or energy and related products (including tax and environmental credits and heating and cooling) produced from such Non-Core Energy Project and any indemnification in connection with the tax equity financing (including sale leaseback financing) of such Non-Core Energy Project; provided, however, that no Non-Core Energy Project Guaranty shall guarantee the Indebtedness of any Person (or in the case of any sale leaseback financing of such Non-Core Energy Project, any basic rent).
”Non-Core Energy Subsidiary” means (i) any Renewable Energy Subsidiary and (ii) any other direct or indirect subsidiary of the Borrower formed for the purpose of financing, constructing or operating any Non-Core Energy Project.
“Restricted Junior Payment” means (i) any dividend or other distribution, direct or indirect, on account of any shares of any class of Equity Interest in, any Loan Party or any Subsidiary now or hereafter outstanding, except a dividend payable solely in shares of Equity Interests, (ii) any redemption, retirement, sinking fund or similar payment, purchase or other acquisition for value, direct or indirect, of any shares of any class of Equity Interest in, any Loan Party or any Subsidiary now or hereafter outstanding by such Loan Party or Subsidiary, (iii) any payment made to retire, or to obtain the surrender of, any outstanding warrants, options or other rights to acquire shares of any class of Equity Interest in, any Loan Party or any Subsidiary, (iv) any payment or prepayment of principal of, premium, if any, or interest on, or redemption purchase, retirement, defeasance (including economic or legal defeasance), sinking fund or similar payment with respect to, any Subordinated Indebtedness, and (v) any payment made to any Affiliates of any Loan Party or any Subsidiary in respect of management, consulting or other similar services provided to any Loan Party or any Subsidiary..
“Special Purpose Subsidiaries” means the Hawaii Joint Venture and the Non-Core Energy Subsidiaries. 
(b)    Section 1.01 of the Credit Agreement is hereby further amended to insert the following new definitions in alphabetical order:
3

“Alternative Currency Daily Rate” means, for any day, with respect to any Credit Extension:
(a)    denominated in Sterling, the rate per annum equal to SONIA determined pursuant to the definition thereof plus the SONIA Adjustment; and
(b)    denominated in any other Alternative Currency (to the extent such Loans denominated in such currency will bear interest at a daily rate), the daily rate per annum as designated with respect to such Alternative Currency at the time such Alternative Currency is approved by the Agent and the relevant Lenders pursuant to Section 1.11(a) plus the adjustment (if any) determined by the Agent and the relevant Lenders pursuant to Section 1.11(a);
provided, that, if any Alternative Currency Daily Rate shall be less than zero, such rate shall be deemed zero for purposes of this Agreement.  Any change in an Alternative Currency Daily Rate shall be effective from and including the date of such change without further notice.
“Alternative Currency Daily Rate Loan” means a Loan that bears interest at a rate based on the Alternative Currency Daily Rate.”  
“Amendment No. 2” means Amendment No. 2 to Fourth Amended and Restated Credit Agreement dated as of June 22, 2021, among the Borrower, the Guarantors, the Lenders and the Agent.
“Amendment No. 2 Effective Time” means the first Business Day on which each of the conditions of the effectiveness of Amendment No. 2 pursuant to Section 6 thereof has been satisfied.
“Available Tenor” means, as of any date of determination and with respect to the then-current Benchmark, as applicable, (x) if the then-current Benchmark is a term rate, any tenor for such Benchmark that is or may be used for determining the length of an Interest Period or (y) otherwise, any payment period for interest calculated with reference to such Benchmark, as applicable, pursuant to this Agreement as of such date.
“Benchmark” means, initially, LIBOR; provided that if a replacement of the Benchmark has occurred pursuant to Section 3.03(c) then “Benchmark” means the applicable Benchmark Replacement to the extent that such Benchmark Replacement has replaced such prior benchmark rate. Any reference to “Benchmark” shall include, as applicable, the published component used in the calculation thereof.
“Benchmark Replacement” means:
(1)    For purposes of Section 3.03(c)(i), the first alternative set forth below that can be determined by the Agent:
(a)    the sum of: (i) Term SOFR and (ii) 0.11448% (11.448 basis points) for an Available Tenor of one-month’s duration, 0.26161% (26.161 basis points) for an Available Tenor of three-months’ duration, 0.42826% (42.826 basis points) for an Available Tenor of six-months’ duration, and 0.71513% (71.513 basis points) for an Available Tenor of twelve-months’ duration, or
4

(b)    the sum of: (i) Daily Simple SOFR and (ii) 0.26161% (26.161 basis points); 
provided that, if initially LIBOR is replaced with the rate contained in clause (b) above (Daily Simple SOFR plus the applicable spread adjustment) and subsequent to such replacement, the Agent determines that Term SOFR has become available and is administratively feasible for the Agent in its sole discretion, and the Agent notifies the Borrower and each Lender of such availability, then from and after the beginning of the Interest Period, relevant interest payment date or payment period for interest calculated, in each case, commencing no less than thirty (30) days after the date of such notice, the Benchmark Replacement shall be as set forth in clause (a) above; and
(2)    For purposes of Section 3.03(c)(ii), the sum of (a) the alternate benchmark rate and (b) an adjustment (which may be a positive or negative value or zero), in each case, that has been selected by the Agent and the Borrower as the replacement Benchmark giving due consideration to any evolving or then-prevailing market convention, including any applicable recommendations made by a Relevant Governmental Body, for U.S. dollar-denominated syndicated credit facilities at such time; 
provided that, if the Benchmark Replacement as determined pursuant to clause (1) or (2) above would be less than 0%, the Benchmark Replacement will be deemed to be 0% for the purposes of this Agreement and the other Loan Documents.
Any Benchmark Replacement shall be applied in a manner consistent with market practice; provided that to the extent such market practice is not administratively feasible for the Agent, such Benchmark Replacement shall be applied in a manner as otherwise reasonably determined by the Agent.
“Benchmark Replacement Conforming Changes” means, with respect to any Benchmark Replacement, any technical, administrative or operational changes (including changes to the definition of “Base Rate,” the definition of “Business Day,” the definition of “Interest Period,” timing and frequency of determining rates and making payments of interest, timing of borrowing requests or prepayment, conversion or continuation notices, the applicability and length of lookback periods, the applicability of breakage provisions, and other technical, administrative or operational matters) that the Agent decides may be appropriate to reflect the adoption and implementation of such Benchmark Replacement and to permit the administration thereof by the Agent in a manner substantially consistent with market practice (or, if the Agent decides that adoption of any portion of such market practice is not administratively feasible or if the Agent determines that no market practice for the administration of such Benchmark Replacement exists, in such other manner of administration as the Agent decides is reasonably necessary in connection with the administration of this Agreement and the other Loan Documents).
“Benchmark Transition Event” means, with respect to any then-current Benchmark other than LIBOR, the occurrence of a public statement or publication of information by or on behalf of the administrator of the then-current Benchmark or a Governmental Authority with jurisdiction over such administrator announcing or stating that all Available Tenors are or will no longer be representative, or made available, or used for determining the interest rate of loans, or shall or will otherwise cease, provided that, at the time of such statement or publication, there is 
5

no successor administrator that is satisfactory to the Agent, that will continue to provide any representative tenors of such Benchmark after such specific date. 
“Daily Simple SOFR” with respect to any applicable determination date means the secured overnight financing rate (“SOFR”) published on such date by the Federal Reserve Bank of New York, as the administrator of the benchmark (or a successor administrator) on the Federal Reserve Bank of New York’s website (or any successor source).
“Early Opt-in Effective Date” means, with respect to any Early Opt-in Election, the sixth (6th) Business Day after the date notice of such Early Opt-in Election is provided to the Lenders, so long as the Agent has not received, by 5:00 p.m. (New York City time) on the fifth (5th) Business Day after the date notice of such Early Opt-in Election is provided to the Lenders, written notice of objection to such Early Opt-in Election from Lenders comprising the Required Lenders.
“Early Opt-in Election” means the occurrence of:
(1)    a determination by the Agent, or a notification by the Borrower to the Agent that the Borrower has made a determination, that U.S. dollar-denominated syndicated credit facilities currently being executed, or that include language similar to that contained in Section 3.03(c), are being executed or amended (as applicable) to incorporate or adopt a new benchmark interest rate to replace LIBOR, and 
(2)    the joint election by the Agent and the Borrower to replace LIBOR with a Benchmark Replacement and the provision by the Agent of written notice of such election to the Lenders.
“Mentoring Joint Venture” means a Person formed by a Loan Party, or in which a Loan Party acquires an Equity Interest, and in which a Loan Party serves as a mentor to a small, or disadvantaged business in the United States Small Business Administration’s Mentor-Protege Program.
“Other Rate Early Opt-in” means the Agent and the Borrower have elected to replace LIBOR with a Benchmark Replacement other than a SOFR-based rate pursuant to (1) an Early Opt-in Election and (2) Section 3.03(c)(ii) and paragraph (2) of the definition of “Benchmark Replacement”.
“Relevant Governmental Body” means the Board of Governors of the Federal Reserve System or the Federal Reserve Bank of New York, or a committee officially endorsed or convened by the Board of Governors of the Federal Reserve System or the Federal Reserve Bank of New York, or any successor thereto.
“SOFR Early Opt-in” means the Agent and the Borrower have elected to replace LIBOR pursuant to (1) an Early Opt-in Election and (2) Section 3.03(c)(i) and paragraph (1) of the definition of “Benchmark Replacement”. 
“SONIA” means, with respect to any applicable determination date, the Sterling Overnight Index Average Reference Rate published on such date on the applicable Reuters screen page (or such other commercially available source providing such quotations as may be 
6

designated by the Agent from time to time); provided that if such day is not a Business Day, then SONIA means such rate published on the Business Day immediately prior thereto.
“SONIA Adjustment” means, with respect to SONIA, 0.1193%.
“TARGET Day” means any day on which TARGET2 (or, if such payment system ceases to be operative, such other payment system, if any, determined by the Agent to be a suitable replacement) is open for the settlement of payments in Euro.
“Term SOFR” means, for the applicable corresponding tenor (or if any Available Tenor of a Benchmark does not correspond to an Available Tenor for the applicable Benchmark Replacement, the closest corresponding Available Tenor and if such Available Tenor corresponds equally to two Available Tenors of the applicable Benchmark Replacement, the corresponding tenor of the shorter duration shall be applied), the forward-looking term rate based on SOFR that has been selected or recommended by the Relevant Governmental Body.
(c)    Section 2.08(c) of the Credit Agreement is hereby amended by deleting clause (iv) in its entirety (and without affecting the final sentence of Section 2.08(c)) and replacing clause (iv) with the following:  
(iv)    Payments by Borrower; Presumptions by Agent.  Unless the Agent shall have received notice from the Borrower prior to the date on which any payment is due to the Agent for the account of the Lenders or the L/C Issuer hereunder that the Borrower will not make such payment, the Agent may assume that the Borrower has made such payment on such date in accordance herewith and may, in reliance upon such assumption, distribute to the Lenders or the L/C Issuer, as the case may be, the amount due.  With respect to any payment that the Agent makes for the account of the Lenders or the L/C Issuer hereunder as to which the Agent determines (which determination shall be conclusive absent manifest error) that any of the following applies (such payment referred to as the “Rescindable Amount”) : (1) the Borrower has not in fact made such payment; (2) the Agent has made a payment in excess of the amount so paid by the Borrower (whether or not then owed); or (3) the Agent has for any reason otherwise erroneously made such payment; then each of the Lenders or the L/C Issuer, as the case may be, severally agrees to repay to the Agent forthwith on demand the Rescindable Amount so distributed to such Lender or the L/C Issuer, in Same Day Funds with interest thereon, for each day from and including the date such amount is distributed to it to but excluding the date of payment to the Agent, at the greater of the Federal Funds Rate and a rate determined by the Agent in accordance with banking industry rules on interbank compensation.
(d)    Section 3.03 of the Credit Agreement is hereby amended to delete paragraphs (c), (d), (e), (f) and (g) in their entirety and replace them with the following new paragraph (c):
(c)     Notwithstanding anything to the contrary herein or in any other Loan Document:
(i)     On March 5, 2021 the Financial Conduct Authority (“FCA”), the regulatory supervisor of LIBOR’s administrator (“IBA”), announced in a public statement the future cessation or loss of representativeness of overnight/Spot Next, 1-week, 1-month, 2-month, 3-month, 6-month and 12- month U.S. dollar LIBOR tenor settings.  On the earliest of (A) the date that all Available Tenors of U.S. dollar LIBOR have permanently or indefinitely ceased to be provided by IBA or have been announced by the FCA pursuant to public statement or publication of information to be no longer representative, (B) June 30, 2023, and (C) the Early Opt-in 
7

Effective Date in respect of a SOFR Early Opt-in, if the then-current Benchmark is LIBOR, the Benchmark Replacement will replace such Benchmark for all purposes hereunder and under any Loan Document in respect of any setting of such Benchmark on such day and all subsequent settings without any amendment to, or further action or consent of any other party to this Agreement or any other Loan Document.  If the Benchmark Replacement is Daily Simple SOFR, all interest payments will be payable on a quarterly basis.
(ii)    (x) Upon (A) the occurrence of a Benchmark Transition Event or (B) a determination by the Agent that neither of the alternatives under clause (1) of the definition of Benchmark Replacement are available, the Benchmark Replacement will replace the then-current Benchmark for all purposes hereunder and under any Loan Document in respect of any Benchmark setting at or after 5:00 p.m. on the fifth (5th) Business Day after the date notice of such Benchmark Replacement is provided to the Lenders without any amendment to, or further action or consent of any other party to, this Agreement or any other Loan Document so long as the Agent has not received, by such time, written notice of objection to such Benchmark Replacement from Lenders comprising the Required Lenders (and any such objection shall be conclusive and binding absent manifest error); provided that solely in the event that the then-current Benchmark at the time of such Benchmark Transition Event is not a SOFR-based rate, the Benchmark Replacement therefor shall be determined in accordance with clause (1) of the definition of Benchmark Replacement unless the Agent determines that neither of such alternative rates is available. 
(y)    On the Early Opt-in Effective Date in respect of an Other Rate Early Opt-in, the Benchmark Replacement will replace LIBOR for all purposes hereunder and under any Loan Document in respect of any setting of such Benchmark on such day and all subsequent settings without any amendment to, or further action or consent of any other party to this Agreement or any other Loan Document.
(iii)    At any time that the administrator of the then-current Benchmark has permanently or indefinitely ceased to provide such Benchmark or such Benchmark has been announced by the regulatory supervisor for the administrator of such Benchmark pursuant to public statement or publication of information to be no longer representative of the underlying market and economic reality that such Benchmark is intended to measure and that representativeness will not be restored, the Borrower may revoke any request for a borrowing of, conversion to or continuation of Loans to be made, converted or continued that would bear interest by reference to such Benchmark until the Borrower’s receipt of notice from the Agent that a Benchmark Replacement has replaced such Benchmark, and, failing that, the Borrower will be deemed to have converted any such request into a request for a borrowing of or conversion to Base Rate Loans. During the period referenced in the foregoing sentence, the component of Base Rate based upon the Benchmark will not be used in any determination of Base Rate.
(iv)     In connection with the implementation and administration of a Benchmark Replacement, the Agent will have the right to make Benchmark Replacement Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such Benchmark Replacement Conforming Changes will become effective without any further action or consent of any other party to this Agreement.
(v)    The Agent will promptly notify the Borrower and the Lenders of (A) the implementation of any Benchmark Replacement and (B) the effectiveness of any Benchmark 
8

Replacement Conforming Changes. Any determination, decision or election that may be made by the Agent pursuant to this Section 3.03(c), including any determination with respect to a tenor, rate or adjustment or of the occurrence or non-occurrence of an event, circumstance or date and any decision to take or refrain from taking any action, will be conclusive and binding absent manifest error and may be made in its  sole discretion and without consent from any other party hereto, except, in each case, as expressly required pursuant to this Section 3.03(c).  
(vi)    At any time (including in connection with the implementation of a Benchmark Replacement), (A) if the then-current Benchmark is a term rate (including Term SOFR or LIBOR), then the Agent may remove any tenor of such Benchmark that is unavailable or non-representative for Benchmark (including Benchmark Replacement) settings and (B) the Agent may reinstate any such previously removed tenor for Benchmark (including Benchmark Replacement) settings.
(e)    The final paragraph  of Section 5.01 of the Credit Agreement is hereby amended to delete the introductory clause and clause (A) thereof, and replace such text in its entirety with the following:
The term “Collateral” shall in no event include:  (A) the tangible and intangible property and assets of the Special Guarantors or a pledge of the Equity Interests of any Mentoring Joint Venture, Ameresco CT or Ameresco Evansville,
(f)     Paragraph (a) of Section 7.14 of the Credit Agreement is hereby amended to delete the reference to “$5,000,000” in the fourth line and replace it with “$10,000,000.”
(g)    Paragraph 9.01 of the Credit Agreement is hereby amended as follows:
(i)     The references to “$5,000,000” in the fourth line of paragraph (d) and the second line of paragraph (h) are hereby deleted and replaced with “$10,000,000”; and
(ii)    The reference to “$500,000,000 in the last line of paragraph (g) is hereby deleted and replaced with “$600,000,000.”
(h)    Paragraph (j) of Section 9.02 of the Credit Agreement is hereby deleted in its entirety and replaced with the following new paragraph (j):
(j)    Liens on Equity Interests of any Special Purpose Subsidiary (other than the Hawaii Joint Venture) held by any Loan Party or Foreign Subsidiary; provided that such Liens do not encumber any other property or assets of any such Loan Parties or Foreign Subsidiaries; and
(i)    Section 9.03 of the Credit Agreement is here by amended as follows:
i.Paragraph (g) of such Section 9.03 is hereby amended to insert “and Mentoring Joint Ventures” after “Foreign Subsidiaries” in the first line and “or Mentoring Joint Venture” after “Foreign Subsidiary” in the second line;
ii.Paragraph (h) of such Section 9.03 is hereby amended by deleting the introductory of paragraph (h) and clause (h)(i) in their entirety and replacing them with the following new text:
9

(h)    any Non-Core Energy Project Guaranty delivered by the Borrower or any Foreign Subsidiary in connection with a Non-Core Energy Project, provided, however, that:
(i)    one or more of the Core Domestic Ameresco Companies or Non-Core Energy Subsidiaries (or one or more of the Core Ameresco Companies in the case of a Non-Core Energy Project outside the United States of America) shall control the operation and maintenance of the Non-Core Energy Project during the term of the renewable energy purchase or infrastructure agreement with respect to such Non-Core Energy Project; and
iii.Paragraph (j) of such Section 9.03 is hereby amended by deleting in their entirety the final words “under paragraph 3.03(c)(i) of this Section 9.03; and” at the end of paragraph (j) and replacing them with “under paragraph (i) of this Section 9.03;”, and
iv.Paragraph (k) of such Section 9.03 is deleted in its entirety and new paragraphs (k) and (l) are inserted immediately after paragraph (j) as follows:
(k)    Guarantees by a Foreign Subsidiary that is a Non-Core Energy Subsidiary or by a Foreign Subsidiary for which the sole recourse is a Lien permitted by Section 9.02(j); and
(l)    Guarantees of Indebtedness of Mentoring Joint Ventures, provided that such Indebtedness would have been permitted by Section 9.01(g) if it were Indebtedness of a Loan Party.
(j)    Section 9.04 of the Credit Agreement is hereby amended as follows:
i.Paragraph (c) of such Section 9.04 is amended to delete subparagraph (viii) thereof in its entirety and replace it with the following:
(viii) -- any Loan Party may sell, transfer or otherwise dispose of equipment to the extent that (i) such equipment is exchanged for credit against the purchase price of similar replacement equipment, (ii) the proceeds of such disposition are reasonably promptly applied to the purchase price of such replacement equipment, or (iii) such equipment was acquired by, and transferred or sold in the ordinary course of business by such Loan Party, to satisfy its obligations under any construction, operation or similar contract entered into with any third party or Non-Core Energy Subsidiary;
ii.Paragraph (c) of such Section 9.04 is amended to delete “and” at the end of subparagraph (xiii), add “; and” to the end of subparagraph (xiv) and insert new subparagraph (xv) immediately after subparagraph (xiv) as follows:
(xv)    Any Loan Party may acquire Equity Interests in, or form, a Mentoring Joint Venture.
iii.Paragraph (d) of such Section 9.04 is amended to delete subparagraph (ii) thereof in its entirety and replace it with the following:
10

(ii)    both immediately prior to and after giving effect to such Permitted Acquisition on a Pro Forma Basis, incorporating such pro-forma assumptions as are satisfactory to the Agent in its reasonable discretion, (A) the Loan Parties shall be in compliance with the financial covenant set forth in Section 9.10(b) hereof, and (B) the Core Leverage Ratio shall not exceed 3.00 to 1.00;
(k)    Paragraph (a)(vi) of Section 9.05 of the Credit Agreement is hereby amended to insert “or Mentoring Joint Ventures” after “Non-Core Energy Subsidiaries” in the first line thereof.
(l)    Paragraph (e) of Section 9.06 of the Credit Agreement is redesignated as paragraph (f), and paragraph (d) of Section 9.06 of the Credit Agreement is hereby deleted in its entirety and replaced with the following new paragraphs (d) and (e):
(d)    the Borrower may make repurchases of its Equity Interests in an aggregate amount under this paragraph (d) up to $15,000,000 after the Effective Time so long as immediately before and immediately after such repurchase on a Pro Forma Basis, incorporating such pro-forma assumptions as are satisfactory to the Agent in its reasonable discretion, (i) no Default or Event of Default shall have occurred and be continuing, and (ii)(A) the Loan Parties shall be in compliance with the financial covenant set forth in Section 9.10(b), and (B) the Core Leverage Ratio shall not exceed 3.00 to 1.00;
(e)    any Subsidiary of the Borrower may redeem, retire, purchase or otherwise acquire an Equity Interest of such Subsidiary with the proceeds of an Investment in such Subsidiary that is permitted by Section 9.05; and
(m)    Clauses (vi) and (vii) of the proviso in Section 9.08 of the Credit Agreement are hereby amended to change the references to “clause 9.08” at the beginning of each of such clauses (vi) and (vii) to read “clause (a).”
(n)    Section 9.10(a) of the Credit Agreement is hereby deleted in its entirety and replaced with the following new Section 9.10(a):
(a)    Total Funded Debt to EBITDA Ratio.  The Loan Parties shall not permit the Core Leverage Ratio as of the end of each fiscal quarter to exceed 3.50 to 1.00.
(o)    Paragraph (j) of Section 10.01 is hereby amended to delete the reference to “$5,000,000” in the first line and to replace it with “$10,000,000.”
(p)    Article 11 of the Credit Agreement is hereby amended to insert the following new Section 11.13 immediately following Section 11.12, to read as follows:
11.13        Recovery of Erroneous Payments.  Without limitation of any other provision in this Agreement, if at any time the Agent makes a payment hereunder in error to any Lender or the L/C Issuer (the “Credit Party”), whether or not in respect of an Obligation due and owing by the Borrower at such time, where such payment is a Rescindable Amount, then in any such event, each Credit Party receiving a Rescindable Amount severally agrees to repay to the Agent forthwith on demand the Rescindable Amount received by such Credit Party in Same Day Funds in the currency so received, with interest thereon, for each day from and including the date such Rescindable Amount is received by it to but excluding the date of payment to the Agent, at the greater of the Federal Funds Rate and a rate determined by the Agent in accordance 
11

with banking industry rules on interbank compensation.  Each Credit Party irrevocably waives any and all defenses, including any “discharge for value” (under which a creditor might otherwise claim a right to retain funds mistakenly paid by a third party in respect of a debt owed by another) or similar defense to its obligation to return any Rescindable Amount.  The Agent shall inform each Credit Party promptly upon determining that any payment made to such Credit Party comprised, in whole or in part, a Rescindable Amount.
(q)    Schedule 2.01 of the Credit Agreement is hereby amended to delete the table of Revolving Credit Commitment in its entirety and to replace it with the following:
									
	Lender
	Commitment	Applicable percentage
	Bank of America, N.A.	$97,200,000.00	54.000000000%
	Truist Bank, as successor by
merger to SunTrust Bank	$45,000,000.00	25.000000000%
	Webster Bank, N.A.	$37,800,000.00	21.000000000%
	Total Revolving Credit Commitments:	$180,000,000.00
	100%

(r)    Schedule 9.07 of the Credit Agreement is amended to add the following sentence as a new paragraph after the existing text thereof:
The Core Ameresco Companies provide Mentoring Joint Ventures with energy audits, design and construction services, engineering, operations & maintenance, project finance, measurement and verification, asset management, billing, insurance and other administrative services.
(s)    Schedule 1 of Exhibit D to the Credit Agreement is hereby amended to reflect the minimum required Core Leverage Ratio of 3.50 to 1.00.
3.Confirmation of Guaranty by Guarantors. Each Guarantor hereby confirms and agrees that all indebtedness, obligations or liability of the Borrower under the Credit Agreement as amended hereby, whether any such indebtedness, obligations and liabilities are now existing or hereafter arising, due or to become due, absolute or contingent, or direct or indirect, constitute “Guaranteed Obligations” under and as defined in the Credit Agreement and, subject to the limitation set forth in Section 4.01 of the Credit Agreement, are guaranteed by and entitled to the benefits of the Guaranty set forth in Article 4 of the Credit Agreement. Each Guarantor hereby ratifies and confirms the terms and provisions of such Guarantor’s Guaranty and agrees that all of such terms and provisions remain in full force and effect.
4.Confirmation of Security Interests. Each Loan Party (other than the Special Guarantors) hereby confirms and agrees that all indebtedness, obligations and liabilities of the Loan Parties under the Credit Agreement as amended hereby, whether any such indebtedness, obligations and liabilities are now existing or hereafter arising, due or to become due, absolute or contingent, or direct or indirect, constitute “Secured Obligations” under and as defined in the Credit Agreement and are secured by the Collateral and entitled to the benefits of the grant of security interests pursuant to Article 5 of the Credit Agreement. The Loan Parties (other than the Special Guarantors) hereby ratify and confirm the terms and provisions of Article 5 of the Credit Agreement and agree that, after giving effect to this Amendment, all of such terms and provisions remain in full force and effect.
12

5.No Default; Representations and Warranties, etc. The Loan Parties hereby confirm that, after giving effect to this Amendment, (i) the representations and warranties of the Loan Parties contained in Article 7 of the Credit Agreement and the other Loan Documents (A) that contain a materiality qualification are true and correct on and as of the date hereof as if made on such date (except to the extent that such representations and warranties expressly relate to an earlier date), and (B) that do not contain a materiality qualification are true and correct in all material respects on and as of the date hereof as if made on such date (except to the extent that such representations and warranties expressly relate to an earlier date), and (ii) no Default or Event of Default shall have occurred and be continuing. Each Loan Party hereby further represents and warrants that (a) the execution, delivery and performance by such Loan Party of this Amendment (i) have been duly authorized by all necessary action on the part of such Loan Party, (ii) will not violate any applicable law or regulation or the organizational documents of such Loan Party, (iii) will not violate or result in a default under any indenture, agreement or other instrument binding on such Loan Party or any of its assets that will have a Material Adverse Effect, and (iv) do not require any consent, waiver, approval, authorization or order of, or filing, registration or qualification with, any court or governmental authority or any Person (other than the Agent and the Lenders) which has not been made or obtained; and (b) it has duly executed and delivered this Amendment.
6.Conditions to Effectiveness. This Amendment shall become effective upon the receipt by the Agent of all of the following:
(a)    counterparts of this Amendment duly executed by each of the parties hereto or written evidence reasonably satisfactory to the Agent that each of the parties hereto has signed a counterpart of this Amendment;
(b)    duly completed and executed replacement Revolving Notes for the account of each Revolving Lender requesting the same, to be delivered to such Lender, where applicable, in exchange for such Lender’s existing Revolving Note;
(c)    such documents and certificates as the Agent or Special Counsel may reasonably request relating to the organization, existence and good standing of each Loan Party, the authorization of the transactions contemplated hereby and any other legal matters relating to the Loan Parties, this Amendment or the other Loan Documents, all in form and substance reasonably satisfactory to the Agent and Special Counsel;
(d)    evidence satisfactory to the Agent and its Special Counsel that the Loan Parties (other than the Special Guarantors) shall have taken or caused to be taken (or authorized the Agent to take or cause to be taken) all such actions, executed and delivered or caused to be executed and delivered all such agreements, documents and instruments and made or caused to be made all such filings and recordings (other than filings or recordings to be made by the Agent on or after the Amendment No. 2 Effective Time) that may be necessary or, in the opinion of the Agent, desirable in order to create in favor of the Agent, for the benefit of the Lenders, valid and (upon such filing and recording) perfected First Priority security interests in the entire personal and mixed property Collateral;
(e)    a certificate, dated the Amendment No. 2 Effective Time and signed by a Responsible Officer, confirming compliance with the conditions set forth in the first sentence of Section 5 of this Amendment at the Amendment No. 2 Effective Time;
(f)    favorable written opinions (addressed to the Agent and dated the Amendment No. 2 Effective Time) of (i) Morgan, Lewis & Bockius LLP, counsel to the Loan Parties, in form 
13

and substance reasonably satisfactory to the Agent and Special Counsel and covering such matters relating to the Loan Parties, this Amendment, the other Loan Documents or the transactions contemplated hereby as the Agent shall reasonably request and (ii) local counsel to the Loan Parties in the following jurisdictions: Arizona, North Carolina, Nevada, Kentucky, and Tennessee; and
(g)    payment by the Borrower to the Agent for the benefit of the Agent and the Lenders of the amounts provided in a fee letter dated May 20, 2021, between the Borrower and the Agent.
7.Miscellaneous.
(a)    Except to the extent specifically amended hereby, the Credit Agreement, the Loan Documents and all related documents shall remain in full force and effect. This Amendment shall constitute a Loan Document. Whenever the terms or sections amended hereby shall be referred to in the Credit Agreement, Loan Documents or such other documents (whether directly or by incorporation into other defined terms), such defined terms shall be deemed to refer to those terms or sections as amended by this Amendment.
(b)    This Amendment may be executed in any number of counterparts, each of which, when executed and delivered, shall be an original, but all counterparts shall together constitute one instrument. Delivery of an executed counterpart to this Amendment by telecopy or other electronic means shall be effective as an original and shall constitute a representation that an original will be delivered.
(c)    This Amendment shall be governed by the laws of the State of New York and shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns.
(d)    The Loan Parties agree to pay all reasonable expenses, including legal fees and disbursements, incurred by the Agent in connection with this Amendment and the transactions contemplated hereby.
[Signature Pages Follow]
14

IN WITNESS WHEREOF, the parties hereto have executed this Amendment, which shall be deemed to be a sealed instrument as of the date first above written.

BORROWER

AMERESCO, INC.
By:   /s/ Spencer Doran Hole        
Spencer Doran Hole
Senior Vice President and Chief Financial Officer

GUARANTORS

AMERESCO ENERTECH, INC.
AMERESCO FEDERAL SOLUTIONS, INC.
AMERESCO PLANERGY HOUSING, INC.
AMERESCO SELECT, INC.
AMERESCOSOLUTIONS, INC.
APPLIED ENERGY GROUP INC.
SIERRA ENERGY COMPANY
By:   /s/ Spencer Doran Hole        
Spencer Doran Hole
Senior Vice President and Treasurer
AMERESCO SOUTHWEST, INC.

By:   /s/ Spencer Doran Hole        
Spencer Doran Hole
Senior Vice President and Treasurer
E.THREE CUSTOM ENERGY SOLUTIONS, LLC,
By: Sierra Energy Company, its sole member

By:   /s/ Spencer Doran Hole        
Spencer Doran Hole
Senior Vice President and Treasurer
Amendment No. 2 to Fourth Amended and Restated Ameresco Credit and Security Agreement]

AMERESCO ASSET SUSTAINABILITY GROUP LLC
AMERESCO CT LLC
AMERESCO DELAWARE ENERGY LLC
AMERESCO EVANSVILLE LLC
AMERESCO HAWAII LLC
AMERESCO INTELLIGENT SYSTEMS, LLC
AMERESCO LFG HOLDINGS LLC
AMERESCO NAVY YARD PEAKER LLC
AMERESCO PALMETTO LLC
AMERESCO SOLAR LLC
AMERESCO SOLAR NEWBURYPORT LLC
AMERESCO STAFFORD LLC
SELDERA LLC
SOLUTIONS HOLDINGS, LLC

By: Ameresco, Inc., its sole member

By:   /s/ Spencer Doran Hole        
Spencer Doran Hole
Senior Vice President and Chief Financial Officer
AMERESCO SOLAR – PRODUCTS LLC
AMERESCO SOLAR – SOLUTIONS LLC
AMERESCO SOLAR – TECHNOLOGIES LLC
By: Ameresco Solar LLC, its sole member
By: Ameresco, Inc., its sole member

By:   /s/ Spencer Doran Hole        
Spencer Doran Hole
Senior Vice President and Chief Financial Officer

Amendment No. 2 to Fourth Amended and Restated Ameresco Credit and Security Agreement]

AGENT:

BANK OF AMERICA, N.A.

By:   /s/ Henry C. Pennell            
    Name: Henry C. Pennell
    Title: Vice President

LENDERS:

BANK OF AMERICA, N.A.

By:   /s/ John F. Lynch                
    Name: John F. Lynch
    Title: Senior Vice President

Amendment No. 2 to Fourth Amended and Restated Ameresco Credit and Security Agreement]

TRUIST BANK, as successor by merger to SUNTRUST BANK

By:   /s/ Katherine Bass                
    Name: Katherine Bass
    Title: Director

Amendment No. 2 to Fourth Amended and Restated Ameresco Credit and Security Agreement]

WEBSTER BANK, N.A.

By:  /s/ Samuel Pepe            
    Name: Samuel Pepe
    Title: Vice President

Amendment No. 2 to Fourth Amended and Restated Ameresco Credit and Security Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}]]